Andreas Ebbehoj

Researching adrenal tumors - separating the good, the bad and the zebras. Phd at Aarhus University, Denmark + Research Trainee at Mayo Clinic, US.

[Andreas Ebbehoj @AEbbehoj]

Our paper on the socio-economic consequences of #cushing 's syndrome has been accepted in JCEM!
Hope it'll be of value to patients and specialists.
See🧵below for study summary
https://t.co/3RwD2wyz83
@EndoSocJournals @EsbenSonder @HepatoEpi

[Andreas Ebbehoj @AEbbehoj]

@DDEA_Denmark 6/ Thanks to Per Løgstrup Poulsen @EsbenSonder @OlafDekkers Mark Gurnell, Conall Dennedy, Karin Hjorthaug and others for suggestions, inputs, assistance, etc in refining proposal and for future collaboration.

[Andreas Ebbehoj @AEbbehoj]

2 years of pure postdoc primary aldosteronism pleasure coming up! 🥳🎉🍾Brief project explanation in 🧵👇

[Danish Diabetes and Endocrine Academy @DDEA_Denmark]

✨ #DDEA grants 33.9M DKK for research in diabetes, metabolism and endocrinology ✨

30 early-career and 7 visiting researchers will advance knowledge in diabetes, obesity, osteoporosis, and hormone-related fields.

🔗 Read the full press release here: https://t.co/nwqlLGLepm

[Andreas Ebbehoj @AEbbehoj]

5/ Thx to @DDEA_Denmark for sponsoring my next research adventure!

[Anand Vaidya @AnandVaidya17]

We report detailed human studies to show that a substantial proportion of normotensive people exhibit phenotypic signatures of primary aldosteronism -providing mechanistic implications for the pathogenesis and treatment of hypertension @JeniferBrown
https://t.co/eOsWiCg6wD

[Euro J Endocrinology @EJEndo]

#CoMICWednesday
#EJECoMICs Ep 35: NEW @EJEndo paper:
MACS (⬆️cortisol) in adrenal incidentalomas & risk of fragility fractures
https://t.co/N8MBHm6T5U
Created by @SimbaComics led by @Khushikumar__
https://t.co/YxmwjRN8wF
@guidozavatta, @gdd1982
@ESEndocrinology @EsePresident

[Irina Bancos @IrinaBancos]

Patients with #Cushing syndrome suffer significant socioeconomic consequences both prior and after diagnosis. ⁦@AEbbehoj⁩ presenting on this important topic at #ECE2023

[Andreas Ebbehoj @AEbbehoj]

Giants in the field explaining the importance of pre test probability when interpretating lab test for pheo 🧪
Check out the great figures 👇

[Georgios Kyriakos @giorg_kyriakos]

Biochemical Assessment of #Pheochromocytoma and #Paraganglioma
👉 https://t.co/EtQs9pIs9u
@EndoSocJournals @TheEndoSociety

[Andreas Ebbehoj @AEbbehoj]

@DrJuhlin @pepeheffernan @DrBMcGinn Unfortunately I cannot recall and I seem to have misplaced the many mails I get from Her Royal Highness...

[The BMJ @bmj_latest]

The BMJ wants to publish the gold not the mould, the frankincense not the makes-no-sense, and the myrrh not the urrgghh.

This list of 12 statistical issues routinely encountered during peer review aims to help authors of future submissions #ChristmasBMJ
https://t.co/ePYzagXJzL

[Ernesto Schiffrin @ESchiffrin]

Primary Aldosteronism: State-of-the-Art Review https://t.co/DVK2FXiyRi

[Jun Yang @DrJunYang]

Honoured to work with collaborators in Chongqing on a study of Adrenal Tumors in an Unselected Screening Population. @AnnalsofIM 1.4% of 25356 people had adrenal tumors; 69% were non-functioning (in all age brackets), 12% had #PrimaryAldosteronism.
https://t.co/Q4FUZg1nOD

[Andreas Ebbehoj @AEbbehoj]

@IrinaBancos @LMFendo @AnandVaidya17 @tobi_else Only that
1) bladder-PGL incidence didnt change (as seen for pheo & other PGLs due to 📈incidental findings) ➡️ suggests IMO that lots of patients go undiagnosed.
2) Genetic work-up was -ahem- not optimal (~50%) ➡️ a missed opportunity to find and treat affected families.

[Irina Bancos @IrinaBancos]

United multicenter effort between #pheo experts to improve management of bladder #paraganglioma: Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study https://t.co/5DzkQGBFOg @MayoClinicEndo @PheoPara @ParaTroupers1

[Andreas Ebbehoj @AEbbehoj]

Pretty stoked that @EndoSocJournals just published a commentary on our study. Authored by none other than CS experts Susan M Webb & @E_Valassi 😮🤯

https://t.co/BaHu16mEUq

[Andreas Ebbehoj @AEbbehoj]

14/ Study limitations:
No access to clinical data from medical records (recurrence, disease severity, etc).
Validation sample did not indicate that we included any patients with MACS/subclinical CS but one can never be certain.

[Andreas Ebbehoj @AEbbehoj]

Tagging some adrenal/pituitary specialists and groups who might be interested.
@AltieriBarbara @AlePreteUoB @adrenalresearch @ENEAssoc @ENSAT_news @goharmonisation @IrinaBancos @Karavitaki_Niki @Marta_Araujo_C @pituitaryconne1 @PituitarySoc @Yasir_SElhassan @WiebkeArlt

[Irina Bancos @IrinaBancos]

A multicenter study in patients with MACS, mild autonomous cortisol secretion: younger women are most likely to suffer @MayoClinicEndo